Microvascular density, CD68 and tryptase expression in human Diffuse Large B-Cell Lymphoma

Leukemia Research

Volumn 38, Issue 11, 2014, Pages 1374-1377

  Marinaccio, Christian ^a   Ingravallo, Giuseppe ^a   Gaudio, Francesco ^a   Perrone, Tommasina ^a   Nico, Beatrice ^a   Maoirano, Eugenio ^a   Specchia, Giorgina ^a   Ribatti, Domenico ^a,b  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Diffuse Large B Cell Lymphoma; Macrophages; Mast cells; Microvascular density

Indexed keywords

CD68 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; RITUXIMAB; TRYPTASE; VINCRISTINE; CD68 ANTIGEN, HUMAN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CAPILLARY DENSITY; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MALE; MAST CELL; NEOVASCULARIZATION (PATHOLOGY); PROTEIN EXPRESSION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT; ENZYMOLOGY; IMMUNOLOGY; METABOLISM; MICROVASCULATURE; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; FEMALE; HUMANS; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MICROVESSELS; MIDDLE AGED; RETROSPECTIVE STUDIES; TRYPTASES; TUMOR MICROENVIRONMENT;

EID: 84909980026     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2014.09.007     Document Type: Article

References (22)

1. Campo E., Swerdlow S.H., Harris N.L., Pileri S., Stein H., Jaffe E.S. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 2011, 117:5019-5032.
2. Schneider C., Pasqualucci L., Dalla-Favera R. Molecular pathogenesis of diffuse large B-cell lymphoma. Semin Diagn Pathol 2011, 28:167-177.
3. Cai Q.-c., Liao H., Lin S.-x., Xia Y., Wang X.-x., Gao Y., et al. High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma. Med Oncol 2012, 29:2317-2322.
4. Marchesi F., Cirillo M., Bianchi A., Gately M., Olimpieri O.M., Cerchiara E., et al. High density of CD68+/CD163+ tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma. Hematol Oncol 2014, 10.1002/hon.2142.
5. Hedstrom G., Berglund M., Molin D., Fischer M., Nilsson G., Thunberg U., et al. Mast cell infiltration is a favourable prognostic factor in diffuse large B-cell lymphoma. Br J Haematol 2007, 138:68-71.
6. Ribatti D. Mast cells and macrophages exert beneficial and detrimental effects on tumor progression and angiogenesis. Immunol Lett 2013, 152:83-88.
7. Nico B., Benagiano V., Mangieri D., Maruotti N., Vacca A., Ribatti D. Evaluation of microvascular density in tumors: pro and contra. Histol Histopathol 2008, 23:601-607.
8. Ammendola M., Sacco R., Sammarco G., Donato G., Zuccalà V., Luposella M., et al. Mast cells density positive to tryptase correlates with angiogenesis in pancreatic ductal adenocarcinoma patients having undergone surgery. Gastroenterol Res Pract 2014, 2014:951957.
9. Leek R.D., Hunt N.C., Landers R.J., Lewis C.E., Royds J.A., Harris A.L. Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer. J Pathol 2000, 190:430-436.
10. Ullah E., Nagi A.H., Ashraf M. Angiogenesis and mast cell density as predictors of patient survival in squamous cell carcinoma of lung. J Cancer Res Ther 2013, 9:701-705.
11. Wu H., Xu J.-B., He Y.-L., Peng J.-J., Zhang X.-H., Chen C.-Q., et al. Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer. J Surg Oncol 2012, 106:462-468.
12. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
13. Naldini A., Carraro F. Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy 2005, 4:3-8.
14. Egami K., Murohara T., Shimada T., Sasaki K-I., Shintani S., Sugaya T., et al. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 2003, 112:67-75.
15. Lin E.Y., Li J.-F., Gnatovskiy L., Deng Y., Zhu L., Grzesik D.A., et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res 2006, 66:11238-11246.
16. Koh Y.W., Park C-S., Yoon D.H., Suh C., Huh J. CD163 expression was associated with angiogenesis and shortened survival in patients with uniformly treated classical Hodgkin lymphoma. PLOS ONE 2014, 9.
17. Ohri C.M., Shikotra A., Green R.H., Waller D.A., Bradding P. The tissue microlocalisation and cellular expression of CD163, VEGF, HLA-DR, iNOS, and MRP 8/14 is correlated to clinical outcome in NSCLC. PLoS ONE 2011, 6.
18. Farinha P., Masoudi H., Skinnider B.F., Shumansky K., Spinelli J.J., Gill K., et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 2005, 106:2169-2174.
19. Blair R.J., Meng H., Marchese M.J., Ren S., Schwartz L.B., Tonnesen M.G., et al. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J Clin Invest 1997, 99:2691-2700.
20. de Souza D.A., Toso V.D., Campos M.R.C., Lara V.S., Oliver C., Jamur M.C. Expression of mast cell proteases correlates with mast cell maturation and angiogenesis during tumor progression. PLOS ONE 2012, 7.
21. Ribatti D., Ranieri G., Nico B., Benagiano V., Crivellato E. Tryptase and chymase are angiogenic in vivo in the chorioallantoic membrane assay. Int J Dev Biol 2011, 55:99-9102.
22. Ribatti D., Vacca A., Marzullo A., Nico B., Ria R., Roncali L., et al. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int J Cancer 2000, 85:171-175.